• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性选择性5-HT1、5-HT2、5-HT3受体及α2肾上腺素能受体阻断对纳洛酮诱导的抗伤害感受的影响。

Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception.

作者信息

Walker M J, Poulos C X, Le A D

机构信息

Addiction Research Foundation, Toronto, Ontario, Canada.

出版信息

Psychopharmacology (Berl). 1994 Jan;113(3-4):527-33. doi: 10.1007/BF02245234.

DOI:10.1007/BF02245234
PMID:7862870
Abstract

Several studies have demonstrated a paradoxical form of antinociception induced by the repeated administration of opioid antagonists accompanied by exposure to a painful stimulus. The underlying mechanism of this naloxone-induced antinociception (NIA) is still unknown, but the results of several studies suggest that it is a non-opioid response. This study was designed to investigate serotonergic and noradrenergic involvement in NIA. Rats were treated daily with systemic injections of 5 mg/kg naloxone, followed by a 45-s hot plate test of nociception (temperature = 51.5 +/- 0.5 degree C). After rats reached plateau levels of NIA, they received a test trial in which they were treated with various doses of different selective 5-HT or alpha 2 adrenoceptor antagonists in addition to naloxone before the hot plate test. Rats treated with 0.16, 0.32 and 0.63 mg/kg pirenperone or 2.5 mg/kg ritanserin showed significant reductions in paw lick latency with respect to rats treated with vehicle. In addition, high doses of yohimbine (7.5-10 mg/kg) also effectively reversed NIA. In contrast, NIA was not affected by acute blockade of 5-HT1 or 5-HT3 receptors by methiothepin or MDL 72222, respectively, or by the alpha 2 adrenoceptor blocker idazoxan. None of the 5-HT or alpha 2 adrenoceptor antagonists had any effect on the paw lick latencies of saline-treated rats. A possible role of 5-HT2 receptors in the antinociception induced by opioid receptor blockade is discussed.

摘要

多项研究表明,反复给予阿片类拮抗剂并同时暴露于疼痛刺激下会诱发一种矛盾形式的抗伤害感受。这种纳洛酮诱发的抗伤害感受(NIA)的潜在机制尚不清楚,但多项研究结果表明这是一种非阿片类反应。本研究旨在调查5-羟色胺能和去甲肾上腺素能在NIA中的作用。每天给大鼠全身注射5mg/kg纳洛酮,随后进行45秒的热板伤害感受测试(温度=51.5±0.5摄氏度)。在大鼠达到NIA的稳定水平后,进行一次测试试验,即在热板测试前,除了给予纳洛酮外,还给予它们不同剂量的不同选择性5-羟色胺或α2肾上腺素能受体拮抗剂进行治疗。用0.16、0.32和0.63mg/kg的匹泮哌隆或2.5mg/kg的利坦色林治疗的大鼠,与用赋形剂治疗的大鼠相比,爪舔潜伏期显著缩短。此外,高剂量的育亨宾(7.5-10mg/kg)也能有效逆转NIA。相比之下,分别用甲硫哒嗪或MDL 72222对5-HT1或5-HT3受体进行急性阻断,或用α2肾上腺素能受体阻滞剂咪唑克生,均不影响NIA。5-羟色胺或α2肾上腺素能受体拮抗剂对用生理盐水治疗的大鼠的爪舔潜伏期均无任何影响。本文讨论了5-HT2受体在阿片受体阻断诱发的抗伤害感受中的可能作用。

相似文献

1
Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception.急性选择性5-HT1、5-HT2、5-HT3受体及α2肾上腺素能受体阻断对纳洛酮诱导的抗伤害感受的影响。
Psychopharmacology (Berl). 1994 Jan;113(3-4):527-33. doi: 10.1007/BF02245234.
2
Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.在大鼠急性疼痛模型中,脊髓上阿片受体和GABA受体可能参与胞磷胆碱诱导的抗伤害感受作用。
Neurosci Lett. 2007 Jun 13;420(2):116-21. doi: 10.1016/j.neulet.2007.04.058. Epub 2007 Apr 29.
3
Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.脑室内注射吗啡通过激活脊髓中的5-羟色胺3受体,引起γ-氨基丁酸释放,从而产生抗伤害感受作用。
Anesthesiology. 2002 May;96(5):1175-82. doi: 10.1097/00000542-200205000-00022.
4
An investigation of monoamine receptors involved in antinociceptive effects of antidepressants.参与抗抑郁药镇痛作用的单胺受体研究。
Anesth Analg. 2002 Jul;95(1):163-8, table of contents. doi: 10.1097/00000539-200207000-00029.
5
Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.曲马朵的镇痛作用可被可乐定通过 α₂-肾上腺素能和 I₂-咪唑啉受体增强,但不能被内皮素 ET(A)受体增强,在小鼠中。
Eur J Pharmacol. 2012 May 15;683(1-3):109-15. doi: 10.1016/j.ejphar.2012.03.016. Epub 2012 Mar 16.
6
Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.大鼠烟碱样镇痛作用中的肾上腺素能、5-羟色胺能和胆碱能成分
J Pharmacol Exp Ther. 1993 May;265(2):777-89.
7
Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice.血清素与疼痛:有证据表明,激活5-HT1A受体不会引发小鼠对有害热、机械和化学刺激的抗伤害感受作用。
Pain. 1994 Jul;58(1):45-61. doi: 10.1016/0304-3959(94)90184-8.
8
Effects of yohimbine on naloxone-induced antinociception in a rat model of inflammatory hyperalgesia.育亨宾对炎性痛觉过敏大鼠模型中纳洛酮诱导的抗伤害感受的影响。
Eur J Pharmacol. 1998 May 8;348(2-3):161-5. doi: 10.1016/s0014-2999(98)00151-4.
9
Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.α(2C)-肾上腺素能受体亚型和内源性阿片肽可能参与赛拉嗪诱导的外周抗伤害感受作用。
Eur J Pharmacol. 2009 Apr 17;608(1-3):23-7. doi: 10.1016/j.ejphar.2009.02.019. Epub 2009 Feb 21.
10
Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors.育亨宾在大鼠福尔马林试验中产生抗伤害感受作用:5-羟色胺(1A)受体的参与。
Psychopharmacology (Berl). 2000 Mar;149(1):93-7. doi: 10.1007/s002139900343.

引用本文的文献

1
The relationship between resting blood pressure and acute pain sensitivity: effects of chronic pain and alpha-2 adrenergic blockade.静息血压与急性疼痛敏感性之间的关系:慢性疼痛和α-2肾上腺素能阻滞的影响。
J Behav Med. 2008 Feb;31(1):71-80. doi: 10.1007/s10865-007-9133-4. Epub 2007 Oct 17.

本文引用的文献

1
Naloxone potentiation of novelty-induced hypoalgesia: characterization of the alpha-noradrenergic receptor subtype.
Pharmacol Biochem Behav. 1993 Feb;44(2):381-6. doi: 10.1016/0091-3057(93)90478-c.
2
A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.麦角酸二乙酰胺(LSD)的药物辨别分析:所谓的5-羟色胺拮抗剂以及LSD拮抗剂匹仑哌隆的体内激动剂和拮抗剂作用
J Pharmacol Exp Ther. 1982 Apr;221(1):206-14.
3
Potentiation of cold-water swim analgesia and hypothermia by clonidine.
Pharmacol Biochem Behav. 1983 Sep;19(3):447-51. doi: 10.1016/0091-3057(83)90118-1.
4
Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord.含5-羟色胺的神经元参与向中缝大核内注射吗啡或向脊髓上注射吗啡所产生的抗伤害感受作用。
Brain Res. 1984 Jul 23;306(1-2):341-8. doi: 10.1016/0006-8993(84)90384-6.
5
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.MDL 72222:一种强效且高度选择性的神经元5-羟色胺受体拮抗剂。
Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36-44. doi: 10.1007/BF00518776.
6
Organization of endogenous opiate and nonopiate pain control systems.内源性阿片类和非阿片类疼痛控制系统的组织
Science. 1982 Jun 11;216(4551):1185-92. doi: 10.1126/science.6281891.
7
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.新型5-羟色胺2受体拮抗剂R 41 468的受体结合情况
Life Sci. 1981 Mar 2;28(9):1015-22. doi: 10.1016/0024-3205(81)90747-5.
8
Stress analgesia: effects of PCPA, yohimbine, and naloxone.应激镇痛:对氯苯丙氨酸、育亨宾和纳洛酮的作用
Pharmacol Biochem Behav. 1984 Nov;21(5):681-6. doi: 10.1016/s0091-3057(84)80002-7.
9
Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.咪唑克生(RX 781094)、育亨宾、萝芙素和柯楠碱的α-肾上腺素能受体拮抗剂特性比较。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Feb;325(2):136-44. doi: 10.1007/BF00506193.
10
Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor.育亨宾:一种用于研究α2-肾上腺素能受体的药理学探针。
Pharmacol Rev. 1983 Sep;35(3):143-80.